Mild Cognitive Impairment Mild Cognitive Impairment, MCI, Cognitive Dysfunctions, Cognitive Impairments
Conditions
Interventions
None listed
Sponsors
Ito Daisuke
Eligibility
Inclusion criteria
Inclusion criteria: NC Elderly Group: (1) Age between 60 and 89 years old at the time of consent (2) Self-confirmation that ADL is maintained MCI patient group: (1) Age at the time of consent: 60-89 years old (2) MMSE score between 24 and 27 (3) Patients with well-controlled side effects of dementia treatment
Exclusion criteria
Exclusion criteria: Elderly NC group: (1) Patients receiving antidepressants, antipsychotics, long-term hypnotic sedatives including sleeping pills (including anxiolytics), having or being treated for epilepsy, or having a history of psychiatric or neurological disorders affecting cognitive function (schizophrenia, mood disorders, anxiety disorders, etc.) 2) Have color blindness. MCI group: (1) Antidepressants, antipsychotics, long-term administration of hypnotic sedatives including sleeping pills (including anxiolytics), history or treatment of epilepsy, and history of psychiatric or neurological disorders affecting cognitive function (schizophrenia, mood disorders, anxiety disorders, etc.) 2) Have color blindness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Correlations between Delayed Recognition Task Performance and MMSE Scores Between NC Elderly and MCI Groups | — |
Secondary
| Measure | Time frame |
|---|---|
| - Cutoff values for discriminating between the NC elderly group and the MCI group in the delayed recognition task. - Correlations between total CQ memory score and various neuropsychological tests such as MMSE - Cutoff values for discriminating between the NC elderly group and the MCI group in the total score of CQ memory - Safety of CQ memory and usefulness of CQ memory based on the severity, severity, causality, and outcome of failure events. | — |
Contacts
Public ContactAtsuko Senba
Splink,Inc.
Outcome results
None listed